Neuros Medical, Willoughby, Ohio, announced that it has received an Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) allowing it to commence a clinical trial to evaluate the company’s patented Altius™ System High Frequency Nerve Block technology for the management of intractable limb pain of individuals with amputations.
